News Positive results announced for ViiV Healthcare's two-drug HI... A two-drug strategy has shown positive results, giving new hope to patients with HIV.
News ViiV's HIV drug could be used for TB co-infection patients Interim results suggest new treatment option for patients with TB and HIV
News ViiV to begin trials of HIV prevention injection GSK hopes patients will prefer PrEP injection to pills.
News AbbVie gets continuous Parkinson's drug over the line in US AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.